| Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations L Decoster, K Van Puyvelde, S Mohile, U Wedding, U Basso, G Colloca, ... Annals of Oncology 26 (2), 288-300, 2015 | 805 | 2015 |
| The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first … JJ Ko, W Xie, N Kroeger, J Lee, BI Rini, JJ Knox, GA Bjarnason, S Srinivas, ... The lancet oncology 16 (3), 293-300, 2015 | 387 | 2015 |
| Management of patients with advanced prostate cancer: report of the advanced prostate cancer consensus conference 2019 S Gillessen, G Attard, TM Beer, H Beltran, A Bjartell, A Bossi, A Briganti, ... European urology 77 (4), 508-547, 2020 | 384 | 2020 |
| Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus G Curigliano, S Banerjee, A Cervantes, MC Garassino, P Garrido, ... Annals of Oncology 31 (10), 1320-1335, 2020 | 331 | 2020 |
| Analysis of prognostic factors of comprehensive geriatric assessment and development of a clinical scoring system in elderly Asian patients with cancer R Kanesvaran, H Li, KN Koo, D Poon Journal of clinical oncology 29 (27), 3620-3627, 2011 | 230 | 2011 |
| Evaluation of clear cell, papillary, and chromophobe renal cell carcinoma metastasis sites and association with survival S Dudani, G De Velasco, JC Wells, CL Gan, F Donskov, C Porta, ... JAMA network open 4 (1), e2021869-e2021869, 2021 | 177 | 2021 |
| Change in neutrophil-to-lymphocyte ratio in response to targeted therapy for metastatic renal cell carcinoma as a prognosticator and biomarker of efficacy AJ Templeton, JJ Knox, X Lin, R Simantov, W Xie, N Lawrence, R Broom, ... European urology 70 (2), 358-364, 2016 | 172 | 2016 |
| Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer GGY Lai, TH Lim, J Lim, PJR Liew, XL Kwang, R Nahar, ZW Aung, ... Journal of clinical oncology 37 (11), 876-884, 2019 | 120 | 2019 |
| Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost … AC Tan, GGY Lai, G San Tan, SY Poon, B Doble, TH Lim, ZW Aung, ... Lung Cancer 139, 207-215, 2020 | 113 | 2020 |
| Priorities for the global advancement of care for older adults with cancer: an update of the International Society of Geriatric Oncology Priorities Initiative M Extermann, E Brain, B Canin, MN Cherian, KL Cheung, N de Glas, ... The Lancet Oncology 22 (1), e29-e36, 2021 | 107 | 2021 |
| Outcome of patients with metastatic sarcomatoid renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium CE Kyriakopoulos, N Chittoria, TK Choueiri, N Kroeger, JL Lee, S Srinivas, ... Clinical genitourinary cancer 13 (2), e79-e85, 2015 | 107 | 2015 |
| Global geriatric oncology: achievements and challenges E Soto-Perez-de-Celis, NA de Glas, T Hsu, R Kanesvaran, C Steer, ... Journal of Geriatric Oncology 8 (5), 374-386, 2017 | 101 | 2017 |
| The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate MC Garassino, M Vyas, EGE De Vries, R Kanesvaran, R Giuliani, ... Annals of oncology 32 (5), 579-581, 2021 | 94 | 2021 |
| Elderly patients with metastatic renal cell carcinoma: position paper from the International Society of Geriatric Oncology R Kanesvaran, O Le Saux, R Motzer, TK Choueiri, F Scotté, J Bellmunt, ... The Lancet Oncology 19 (6), e317-e326, 2018 | 93 | 2018 |
| Third-line targeted therapy in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium JC Wells, I Stukalin, C Norton, S Srinivas, JL Lee, F Donskov, ... European urology 71 (2), 204-209, 2017 | 89 | 2017 |
| Immunotherapy in older adults with advanced cancers: implications for clinical decision-making and future research R Kanesvaran, R Cordoba, R Maggiore American Society of Clinical Oncology Educational Book 38, 400-414, 2018 | 88 | 2018 |
| Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer Consensus Conference (APCCC … S Gillessen, A Bossi, ID Davis, J de Bono, K Fizazi, ND James, N Mottet, ... European journal of cancer 185, 178-215, 2023 | 83 | 2023 |
| Management of patients with advanced prostate cancer: report from the Advanced Prostate Cancer Consensus Conference 2021 S Gillessen, A Armstrong, G Attard, TM Beer, H Beltran, A Bjartell, A Bossi, ... European urology 82 (1), 115-141, 2022 | 83 | 2022 |
| Comparison of preferences for end-of-life care among patients with advanced cancer and their caregivers: a discrete choice experiment C Malhotra, MA Farooqui, R Kanesvaran, M Bilger, E Finkelstein Palliative medicine 29 (9), 842-850, 2015 | 83 | 2015 |
| Management of patients with advanced prostate cancer. Part I: intermediate-/high-risk and locally advanced disease, biochemical relapse, and side effects of hormonal treatment … S Gillessen, A Bossi, ID Davis, J de Bono, K Fizazi, ND James, N Mottet, ... European urology 83 (3), 267-293, 2023 | 80 | 2023 |
